BACKGROUND: Peri-operative hemodynamic instability (HDI) may increase peri-operative morbidity in pheochromocytoma/paraganglioma (PPGL) patients. OBJECTIVE: This study aimed to determine which tumor-related risk factors could lead to peri-operative HDI in unilateral or single PPGL removal. METHODS: Before surgery, 66 PPGL patients had at least two sets of 24 h urine collected for fractionated catecholamine analysis. At surgery, an arterial line was inserted to record systolic blood pressure (SBP), diastolic BP, and mean arterial BP (MAP). Peri-operative HDI was defined as hypertension (SBP > 160 mmHg) and/or hypotension (SBP < 90 mmHg and/or MAP < 60 mmHg) for >10 consecutive minutes either intra-operatively or within the first 12 h after surgery. Urinary fractionated catecholamines and other variables were compared between those with peri-operative HDI (group I) and those without (group II). RESULTS: A total of 15 (22.7 %) patients belonged to group I, while 51 patients belonged to group II. One (1.5 %) patient died 9 days after surgery. Relative to group II, group I had significantly higher urinary norepinephrine (NE) (5,488.0 vs. 1,980.0 nmol/L, p < 0.001), urinary normetanephrine (5,130.9 vs. 3,853.4 nmol/L, p = 0.045), maximum SBP at operation (188.2 vs. 167.4 mmHg, p = 0.037), but lower MAP after operation (78.9 vs. 91.8 mmHg, p = 0.026). Urinary NE (OD 1.02, 95 % confidence interval [CI] 1.01-1.03, p = 0.046) was an independent risk factor for peri-operative HDI. The urinary NE level significantly correlated with maximum intra-operative SBP and MAP (r 0.692, p < 0.001; and r 0.669, p < 0.001, respectively) and inversely correlated with maximum post-operative MAP (r -0.305, p = 0.040). CONCLUSIONS: High pre-operative urinary NE was an independent tumor-related factor for peri-operative HDI and significantly correlated with sustained intra-operative hypertension and post-operative hypotension.
BACKGROUND: Peri-operative hemodynamic instability (HDI) may increase peri-operative morbidity in pheochromocytoma/paraganglioma (PPGL) patients. OBJECTIVE: This study aimed to determine which tumor-related risk factors could lead to peri-operative HDI in unilateral or single PPGL removal. METHODS: Before surgery, 66 PPGL patients had at least two sets of 24 h urine collected for fractionated catecholamine analysis. At surgery, an arterial line was inserted to record systolic blood pressure (SBP), diastolic BP, and mean arterial BP (MAP). Peri-operative HDI was defined as hypertension (SBP > 160 mmHg) and/or hypotension (SBP < 90 mmHg and/or MAP < 60 mmHg) for >10 consecutive minutes either intra-operatively or within the first 12 h after surgery. Urinary fractionated catecholamines and other variables were compared between those with peri-operative HDI (group I) and those without (group II). RESULTS: A total of 15 (22.7 %) patients belonged to group I, while 51 patients belonged to group II. One (1.5 %) patient died 9 days after surgery. Relative to group II, group I had significantly higher urinary norepinephrine (NE) (5,488.0 vs. 1,980.0 nmol/L, p < 0.001), urinary normetanephrine (5,130.9 vs. 3,853.4 nmol/L, p = 0.045), maximum SBP at operation (188.2 vs. 167.4 mmHg, p = 0.037), but lower MAP after operation (78.9 vs. 91.8 mmHg, p = 0.026). Urinary NE (OD 1.02, 95 % confidence interval [CI] 1.01-1.03, p = 0.046) was an independent risk factor for peri-operative HDI. The urinary NE level significantly correlated with maximum intra-operative SBP and MAP (r 0.692, p < 0.001; and r 0.669, p < 0.001, respectively) and inversely correlated with maximum post-operative MAP (r -0.305, p = 0.040). CONCLUSIONS: High pre-operative urinary NE was an independent tumor-related factor for peri-operative HDI and significantly correlated with sustained intra-operative hypertension and post-operative hypotension.
Authors: Ondrej Petrák; Branislav Strauch; Tomás Zelinka; Jan Rosa; Robert Holaj; Alice Vránková; Mojmír Kasalický; Jan Kvasnicka; Karel Pacák; Jirí Widimský Journal: Hypertens Res Date: 2010-02-26 Impact factor: 3.872
Authors: M A Kinney; M E Warner; J A vanHeerden; T T Horlocker; W F Young; D R Schroeder; P M Maxson; M A Warner Journal: Anesth Analg Date: 2000-11 Impact factor: 5.108
Authors: Kent W Kercher; Yuri W Novitsky; Adrian Park; Brent D Matthews; Demetrius E M Litwin; B Todd Heniford Journal: Ann Surg Date: 2005-06 Impact factor: 12.969
Authors: H Bruynzeel; R A Feelders; T H N Groenland; A H van den Meiracker; C H J van Eijck; J F Lange; W W de Herder; G Kazemier Journal: J Clin Endocrinol Metab Date: 2009-12-04 Impact factor: 5.958
Authors: Brian Hung-Hin Lang; Hyeong Won Yu; Chung-Yau Lo; Kyu Eun Lee; Maria-Mercedes Garcia-Barcelo; Yu Cho Woo; Paul C H Lee; Kai Pun Wong; Paul K H Tam; Karen S L Lam Journal: World J Surg Date: 2015-10 Impact factor: 3.352
Authors: Marta Araujo-Castro; Rogelio García Centero; María-Carmen López-García; Cristina Álvarez Escolá; María Calatayud Gutiérrez; Concepción Blanco Carrera; Paz De Miguel Novoa; Nuria Valdés Gallego; Felicia A Hanzu; Paola Gracia Gimeno; Mariana Tomé Fernández-Ladreda; Juan Carlos Percovich Hualpa; Mireia Mora Porta; Javier Lorca Álvaro; Héctor Pian; Ignacio Ruz Caracuel; Alfonso Sanjuanbenito Dehesa; Victoria Gómez Dos Santos; Ana Serrano Romero; Cristina Lamas Oliveira Journal: Endocrine Date: 2021-08-09 Impact factor: 3.633